Differential effects of typical and atypical antipsychotics on MK-801-induced EEG changes in rats

Korean Journal of Physiology and Pharmacology

Volumn 9, Issue 1, 2005, Pages 17-22

  Kwon, Jee Sook ^a   Kim, Ki Min ^a   Chang, Su Min ^a   Kim, Choong Young ^a   Chung, Tai Ho ^b   Choi, Byung Ju ^b   Lee, Maan Gee ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

Antipsychotics; EEG; Linear discriminant analysis; MK 801; Power spectral analysis; Schizophrenia

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; DIZOCILPINE; HALOPERIDOL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DRUG MECHANISM; ELECTROENCEPHALOGRAM; LOCOMOTION; MALE; MULTIVARIATE ANALYSIS; NEGATIVE SYNDROME; NONHUMAN; RAT; SCHIZOPHRENIA; STEREOTYPY;

EID: 14944340208     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ahnaou A, Megens AA, Drinkenburg WH. The atypical antipsychotics risperidone, clozapine and olanzapine differ regarding their sedative potency in rats. Neuropsychobiology 48: 47-54, 2003
2. Arvanov VL, Wang RY. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine. J Pharmacol Exp Ther 289: 1000-1006, 1999
3. Arvanov VL, Liang X, Schwartz J, Grossman S, Wang RY. Clozapine and haloperidol modulate N-methyl-D-aspartate- and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro. J Pharmacol Exp Ther 283: 226-234, 1997
4. Bo P, Ongini E, Giorgetti A, Savoldi F. Synchronization of the EEG and sedation induced by neuroleptics depend upon blockade of both D1 and D2 dopamine receptors. Neuropharmacology 27: 799-805, 1988
5. Corbett R, Camacho F, Woods AT, Kerman LL, Fishkin RJ, Brooks K, Dunn RW. Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology (Berl) 120: 67-74, 1995
6. Deutsch SI, Rosse RB, Billingslea EN, Bellack AS, Mastropaolo J. Topiramate antagonizes MK-801 in an animal model of schizophrenia. Eur J Pharmacol 449: 121-125, 2002
7. Dimpfel W. Preclinical data base of pharmaco-specific rat EEG fingerprints (tele-stereo-EEG). Eur J Med Res 8: 199-207, 2003
8. Dimpfel W, Otten U. Studies of gangliosides in diverse nerve cell cultures. Adv Exp Med Biol 174: 525-534, 1984
9. Dimpfel W, Decker H. Classification of sulpiride, clozapine and haloperidol by toposelective recording from different brain structures in the immobilized rat (stereo-EEG). Neuropsychobiology 14: 157-164, 1985
10. Dimpfel W, Spuler M, Wessel K. Different neuroleptics show common dose and time dependent effects in quantitative field potential analysis in freely moving rats. Psychopharmacology (Berl) 107: 195-202, 1992
11. Goudie AJ, Smith JA. Discriminative stimulus properties of antipsychotics. Pharmacol Biochem Behav 64: 193-201, 1999
12. Herrmann WM. Electroencephalography in drug research: Gustav Fischer Verlag, 1982
13. Hollister LE. Antipsychotic agents and lithium. In: Katzung BG ed, Basic and Clinical Pharmacology. 6th ed. Prentice Hall International, London, p 432-447, 1995
14. Hughes AM, Lynch P, Rhodes J, Ervine CM, Yates RA. Electroencephalographic and psychomotor effects of chlorpromazine and risperidone relative to placebo in normal healthy volunteers. Br J Clin Pharmacol 48: 323-330, 1999
15. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301-1308, 1991
16. Knott V, Labelle A, Jones B, Mahoney C. Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment. Schizophr Res 50: 41-53, 2001.
17. Koek W, Woods JH, Winger GD. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther 245: 969-974, 1988
18. Lim SH, Kwon JS, Kim KM, Park SJ, Park JS, Jeong SH, Lee MG. Basic requirements for spectrum analysis of electroencephalographic effects of central acting drugs. J Appl Pharmacol 8: 63-71, 2000
19. Martin P, Waters N, Carlsson A, Carlsson ML. The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication). J Neural Transm 104: 561-564, 1997
20. McClelland GR, Cooper SM, Pilgrim AJ. A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers. Br J Clin Pharmacol 30: 795-803, 1990
21. Ninan I, Kulkarni SK. Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801. Indian J Physiol Pharmacol 42: 375-382, 1998
22. Sams-Dodd F. Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity. Rev Neurosci 10: 59-90, 1999
23. Seeman P, Corbett R, Van Tol HH. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Neuropsychopharmacology 16: 93-110; discussion 111-135, 1997
24. Smith JA, Boyer-Millar C, Goudie AJ. Does MK-801 discrimination constitute an animal model of schizophrenia useful for detecting atypical antipsychotics? Pharmacol Biochem Behav 64: 429-433, 1999
25. Tiedtke PI, Bischoff C, Schmidt WJ. MK-801-induced stereotypy and its antagonism by neuroleptic drugs. J Neural Transm Gen Sect 81: 173-182, 1990
26. Varty GB, Higgins GA. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacology (Berl) 122: 15-26, 1995
27. Yun JE, Lee MG. Electroencephalographic effects of chlorpromazine in rats. Kor J Physiol Pharmacol 3: 245-250, 1999
28. Zhang W, Pouzet B, Jongen-Relo AL, Weiner I, Feldon J. Disruption of prepulse inhibition following N-methyl-D-aspartate infusion into the ventral hippocampus is antagonized by clozapine but not by haloperidol: a possible model for the screening of atypical antipsychotics. Neuroreport 10: 2533-2538, 1999